INTS
INTENSITY THERAPEUTICS, INC.Company Information
- Company Name
- INTENSITY THERAPEUTICS, INC.
- CIK
- CIK0001567264
- Category
- <br>Emerging growth company
- Ticker: Exchange
- INTS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- INTS
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,146,781
- Shares outstanding
- 2,706,607
- Ownership
- 42.37%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -2.38%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Assets Current | ||||||||||||||||||
| Series B Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Series C Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 10 | 12 | 7 | 2 | 1 | 3 | 3 | 3 | 7 | 9 | 7 | ||||||
| Marketable Securities Current | - | - | - | - | - | - | - | - | - | - | - | 9 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | - | - | - | - | - | - | 0 | 0 | 3 | 3 | 6 | - | ||||||
| Assets Current | 11 | 11 | 13 | 8 | 3 | 2 | 3 | 4 | 7 | 11 | 15 | 17 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | ||||||
| Assets | 12 | 12 | 14 | 10 | 4 | 3 | 5 | 5 | 9 | 12 | 17 | 17 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 3 | 0 | ||||||
| Accrued Liabilities Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 4 | 1 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 4 | 1 | ||||||
Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 93 | 91 | 90 | 83 | 75 | 70 | 70 | 66 | 65 | 65 | 64 | 63 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -84 | -81 | -78 | -75 | -73 | -70 | -67 | -64 | -60 | -55 | -51 | -47 | ||||||
| Stockholders Equity | 9 | 10 | 12 | 7 | 2 | 0 | 3 | 3 | 5 | 10 | 13 | 16 | ||||||
| Liabilities And Stockholders Equity | 12 | 12 | 14 | 10 | 4 | 3 | 5 | 5 | 9 | 12 | 17 | 17 | ||||||
| Series A Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Series B Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Series C Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | ||||||
| Common Stock Shares Issued | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | - | ||||||
| Shares Outstanding | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialINTENSITY THERAPEUTICS, INC. (INTS) — SEC Financial Statements & Analysis
INTENSITY THERAPEUTICS, INC. (INTS) is a biological products, (no diagnostic substances) company, incorporated in DE. INTENSITY THERAPEUTICS, INC. trades on Nasdaq as: INTS. INTENSITY THERAPEUTICS, INC. (INTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, INTENSITY THERAPEUTICS, INC. carries a market cap of $11.10M, a P/E ratio of -0.99x, a P/B ratio of 1.20x, an enterprise value of $1.57M, and an EV/EBITDA multiple of -0.14x. On profitability, it posts a Return on Equity (ROE) of -195.88%, a Return on Assets (ROA) of -139.85%, and a Return on Invested Capital (ROIC) of -228.15%. Per share, it reports EPS of $-4.12, diluted EPS of $-4.12, free cash flow per share of $-3.31, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -11.25% year-over-year and EPS growth of -75.25% year-over-year. On the balance sheet, it maintains a current ratio of 5.00x, a quick ratio of 4.24x, working capital of $8.98M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.2, an interest coverage ratio of -81.05x, free cash flow of $-8.95M (TTM), and net debt of $-9.53M. Figures sourced from SEC EDGAR.
- Market Cap
- $11.10M
- P/E TTM
- -0.99x
- EPS TTM
- $-4.12
- P/B TTM
- 1.20x
- ROE TTM
- -195.88%
- ROA TTM
- -139.85%
- Debt To Equity
- 0.25x
- Free Cash Flow TTM
- $-8.95M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTENSITY THERAPEUTICS, INC. in?
INTENSITY THERAPEUTICS, INC. (INTS) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does INTS trade on?
INTENSITY THERAPEUTICS, INC. (INTS) trades on the Nasdaq.
Where is INTENSITY THERAPEUTICS, INC. incorporated?
INTENSITY THERAPEUTICS, INC. is incorporated in DE.
When was INTENSITY THERAPEUTICS, INC. (INTS)'s most recent SEC filing?
INTENSITY THERAPEUTICS, INC. (INTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is INTS's market cap?
INTENSITY THERAPEUTICS, INC. (INTS) has a market capitalization of $11.10M as of 2026-06-30.
What is INTS's EPS (earnings per share)?
INTENSITY THERAPEUTICS, INC. (INTS)'s trailing twelve month EPS is $-4.12 as of 2026-06-30.
What is INTS's ROE (return on equity)?
INTENSITY THERAPEUTICS, INC. (INTS)'s trailing twelve month Return on Equity (ROE) is -195.88% as of 2026-06-30.
What is INTS's ROA (return on assets)?
INTENSITY THERAPEUTICS, INC. (INTS)'s trailing twelve month Return on Assets (ROA) is -139.85% as of 2026-06-30.
What is INTS's ROIC (return on invested capital)?
INTENSITY THERAPEUTICS, INC. (INTS)'s trailing twelve month Return on Invested Capital (ROIC) is -228.15% as of 2025-12-31.
What is INTS's EV/EBITDA?
INTENSITY THERAPEUTICS, INC. (INTS)'s trailing twelve month EV/EBITDA is -0.14x as of 2026-06-30.